2024
DOI: 10.1001/jamadermatol.2023.5036
|View full text |Cite
|
Sign up to set email alerts
|

Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022

Samir Kamat,
Benjamin Ungar,
Aneesh Agarwal
et al.

Abstract: This cross-sectional study characterizes the frequency and degree of innovation of new dermatologic drugs approved by the US Food and Drug Administration (FDA) from 2012 to 2022.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 8 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?